Member Info for Scharnhorst

Also we used to have LFT manufacturing capacity in Doncaster, but that was sold to Abingdon Health in April 2020 when their valuation would have been more than ten times ours (unable to get exact figure as it was before their IPO). When ABDX listed in December 2020 they were valued at £92m. We can now cover their market cap with cash in hand. Funny old world.

We were informed they closed the lab acquired with genome store.

We don’t produce tests. We just sell other companies’ tests. LFTs look simple but there’s a lot of tech behind them and they can take months if not years to develop.

Aye, aye barchid. Directors went in twice in the 38/39p area so anticipate a good profit from there.
They won't want to be running this in perpetuity, and in the meantime they're building a good strategic business. Old egg avoiding Jug Ears' Most Loyal Opposition are planning to boost investment in small, high growth businesses via the British Business Bank which would suit MERC fine. You need to see the back of the bish bash bosh Boris rabble first though.

For what it's worth, I can't buy 10,000 online without submitting an order, but I can sell 250,000 above the mid-price at the push of a button. I'm not a reader of tea leaves, but I anticipate another leg up as we continue to close the anomalous big discount to NAV.

Due any time now. Remember what was said in September:
"as we work towards a new portfolio and associated launches, which we are excited to share with the market in Q4."

They flagged up an acquisition to increase AUM at the finals.
Immediately earnings enhancing and initial outlay of 4 x EBITDA looks like better value for shareholders than the last one.
Don't mention the world cup. What were we thinking when we employed Herr Flick as manager?

It’s over and done until English do another u-turn.

Thanks for the pig report, doubt I’ll be subscribing though. Director buy today gives a bit more support.

Interesting presentation this morning. Upturn in China underway with good numbers in October and November. Inventories unwinding which will help cash flow.

I’m in for a scooby snack as well. Looked like the company was due an upturn on chart and fundamentals. I’m interested in their viral treatment research for longer term gains. Avian bird flu, another Chinese export, causing massive distress in farmed and wild birds.

OK you win

It would be wrong to say the tiny director buys are a vote of no confidence in the company. They're a vote of very little confidence.

FD has splashed out with £2300.
Give me a break.

We took out the 100 and 200dma a few weeks ago but didn’t hold. I think we will this time and break the downtrend.

Their PR is through Walbrook who I think have been a purveyor of spin for flea-ridden dogs in the healthcare sector. I'd feel more confident if the company ditched them as they suggest 'lifestyle company'.

I think they’ll come up with something good but it’s a frustrating wait.

You talk about them having so much cash (£7m) but they've raised £11.2m from us over the last 5 years.
£4.1m of the cash raised is down to the current board, so not all their bag, but they need to explain to the market how they're going to make money for shareholders going forward.

If you click on the i button to the right of the trade you’ll see it’s a ‘delayed trade’. As we don’t know when the trade was made we can’t know if it was a buy or sell.

Just like it was better to over loosen than under loosen? They’re full of it.